Q3 2025 Bavarian Nordic A/S Earnings Call Transcript

Nov 14, 2025 / 01:00 PM GMT

Release Date Price: €23.66 (-5.17%)

Transcript

Key Points

Positve

Bavarian Nordic AS (BVNKF) reported a 32% increase in total revenues, reaching close to 4.8 billion krona, driven by strong performance across its portfolio.
The company achieved an EBITD margin of 31%, reflecting efficient operations and strong financial health.
The travel health business experienced its strongest quarter, with a 23% increase in sales, highlighting successful strategic execution.
The chikungunya vaccine, Vinunya, was launched in 10 countries and is on track to meet its first-year sales target of 75 million krona.
Bavarian Nordic AS (BVNKF) has transformed from a loss-making R&D-focused company to a profitable vaccine company with a significant impact on global public health.

Negative

The company's guidance for public preparedness revenue is at the lower end of the range, reflecting challenges in securing government contracts.
The chikungunya vaccine launch in the US is facing delays due to the pending MMWR publication, affecting sales traction.
The typhoid vaccine market has declined by approximately 7%, impacting growth despite market share gains.
There is unpredictability in public preparedness revenue due to the nature of government contracts, which can be delayed or canceled unexpectedly.
The company faces ongoing financial obligations, including a $70 million payment to GSK, affecting its cash flow position.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BAVA.CO - Bavarian Nordic A/S
Q3 2025 Bavarian Nordic A/S Earnings Call
Nov 14, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Bavarian Nordic Third Quarterly Report for the nine-month period ended 30th of September 2025 conference call and webcast. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, please press 1 and 1 on your telephone. You will then hear an automated message advising your hand is raised to withdraw your question, please press one and one again.

Please note that today's conference is being recorded. I would now like to send the conference over to your speaker, Mr. Paul Chaplin, CEO. Please go ahead.

--------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.